Verastem (VSTM) Total Debt Growth (3y) (2020 - 2026)
Powered by 
Analysis
Verastem (VSTM) Total Debt Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 19.52% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 4.76% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -22.30% |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn | 22.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.43% |
| Mar 31, 2026 | 21.98% |
| Dec 31, 2025 | 45.46% |
| Sep 30, 2025 | 47.51% |
| Jun 30, 2025 | 45.48% |
| Mar 31, 2025 | 44.06% |
| Sep 30, 2023 | -3.80% |
| Jun 30, 2023 | 0.19% |
| Mar 31, 2023 | 4.75% |
| Dec 31, 2022 | -11.28% |
| Sep 30, 2022 | -11.25% |
| Jun 30, 2022 | -11.23% |
| Mar 31, 2022 | -1.92% |
| Sep 30, 2020 | 168.11% |
| Jun 30, 2020 | 159.54% |
| Mar 31, 2020 | 150.38% |